OTCMKTS:TRUMY Terumo Q4 2025 Earnings Report $14.78 +0.39 (+2.71%) As of 03:58 PM Eastern ProfileEarnings HistoryForecast Terumo EPS ResultsActual EPS$0.08Consensus EPS $0.15Beat/MissMissed by -$0.07One Year Ago EPSN/ATerumo Revenue ResultsActual Revenue$1.79 billionExpected Revenue$1.79 billionBeat/MissMissed by -$7.40 millionYoY Revenue GrowthN/ATerumo Announcement DetailsQuarterQ4 2025Date5/14/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AUpcoming EarningsTerumo's next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Terumo Earnings HeadlinesTerumo Corp. (OTCMKTS:TRUMY) Short Interest UpdateSeptember 27, 2026 | americanbankingnews.comTerumo ADR (TRUMY)September 5, 2026 | es.investing.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 1 at 1:00 AM | Stansberry Research (Ad)Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks TranscriptAugust 12, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Analyst/Investor Day TranscriptJune 12, 2026 | seekingalpha.comTerumo ADR Stock Price HistoryMay 17, 2026 | investing.comSee More Terumo Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email. Email Address About TerumoTerumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services. Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions. Its portfolio includes interventional devices and systems used in cardiovascular procedures, blood collection and processing equipment, transfusion products, infusion and injection devices, and other products designed to support patient care and clinical workflows. The company also provides technologies for diabetes management and other specialized medical applications. Terumo serves healthcare providers and patients internationally through operations and distribution networks spanning Japan, the Americas, Europe, Asia and other markets. Its products are used across a range of medical specialties, including cardiovascular care, blood management, interventional procedures, infusion therapy and hospital operations.View Terumo ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Micron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket ReachJabil’s Double-Beat and Raise Is a Signal That This Rally Will ContinueMicrosoft's AI Spending Didn't Change—Wall Street's View of It DidL3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
